Post by Jean-Ehrland Ricci

A remarkable study showing that a 14-protein blood signature can predict lung cancer more than 5 years before diagnosis. What makes this work particularly important is that it goes beyond prediction. The authors connect environmental exposure (particulate matter), inflammation (IL-1β), and oncogenic EGFR signaling to a common early cellular state linked to tumor initiation. Perhaps most importantly, the signature identifies individuals who may benefit most from anti-IL-1β prevention strategies, moving the field closer to precision cancer prevention. This is an excellent example of combining machine learning, proteomics, single-cell biology, and clinical trial data to translate biological insights into actionable prevention approaches. https://lnkd.in/eNqk-6PK